NEWPORT BEACH, Calif., March 21, 2017 -- Dr. Tom Tooma of NVISION Eye Centers announced today that it is the first practice in Orange County to offer ReLEx® SMILE minimally-invasive laser vision correction. With over 600,000 procedures performed worldwide year to date, ReLEx SMILE is a proven procedure for treatment of myopia or nearsightedness. Only recently, however, was this revolutionary procedure FDA approved to be performed in the U.S.
ReLEx SMILE is the first minimally-invasive laser vision correction procedure available anywhere in the world. This revolutionary procedure developed by ZEISS utilizes the VisuMax® femtosecond laser to create a thin, disc-shaped lenticule within the cornea and a small incision on the surface of the cornea through which the lenticule is subsequently removed by the surgeon. The VisuMax femtosecond laser, which NVISION Eye Centers acquired in February, is the only laser that can currently perform the ReLEx SMILE procedure. With this new treatment option, NVISION Eye Centers, Newport Beach is now offering patients access to the newest, most advanced refractive laser vision correction technology currently available.
“The SMILE procedure is good news for some people who have previously been told they do not qualify for laser eye surgery,“ says Dr. Tom Tooma, founder of NVISION Eye Centers. “Our patients have been benefitting from this innovative procedure in our NVISION Eye Center locations in Toronto for a number of years. The addition of SMILE in Newport Beach helps us to provide the best possible visual result for every lifestyle.”
For more information, call (877) 455-9942 or visit: http://www.nvisioncenters.com.
ABOUT NVISION EYE CENTERS: NVISION Eye Centers is the premier provider of LASIK and cataract surgery in the U.S., with centers in California, Nevada, Oregon, Arizona and Toronto, Canada. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 120,000 procedures throughout his esteemed career. With more than 2,000 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®. For more information, visit www.NVISIONCenters.com or call (877) 455-9942.


Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 



